-Early reexamination of carbohydrate metabolism via an oral glucose tolerance test (OGTT) is recommended after pregnancy with gestational diabetes (GDM). In this report, we aimed to assess the dominant patterns of dynamic OGTT measurements and subsequently explain them by meanings of the underlying pathophysiological processes. Principal components analysis (PCA), a statistical procedure that aims to reduce the dimensionality of multiple interrelated measures to a set of linearly uncorrelated variables (the principal components) was performed on OGTT data of glucose, insulin and C-peptide in addition to age and body mass index (BMI) of 151 women (n ϭ 110 females after GDM and n ϭ 41 controls) at 3-6 mo after delivery. These components were explained by frequently sampled intravenous glucose tolerance test (FSIGT) parameters. Moreover, their relation with the later development of overt diabetes was studied. Three principal components (PC) were identified, which explained 71.5% of the variation of the original 17 variables. PC1 (explained 47.1%) was closely related to postprandial OGTT levels and FSIGT-derived insulin sensitivity (r ϭ 0.68), indicating that it mirrors insulin sensitivity in the skeletal muscle. PC2 (explained 17.3%) and PC3 (explained 7.1%) were shown to be associated with ␤-cell failure and fasting (i.e., hepatic) insulin resistance, respectively. All three components were related with diabetes progression (occurred in n ϭ 25 females after GDM) and showed significant changes in long-term trajectories. A high amount of the postpartum OGTT data is explained by principal components, representing pathophysiological mechanisms on the pathway of impaired carbohydrate metabolism. Our results improve our understanding of the underlying biological processes to provide an accurate postgestational risk stratification. gestational diabetes mellitus; insulin resistance; insulin secretion; oral glucose tolerance test; principal components analysis GESTATIONAL DIABETES MELLITUS (GDM) is characterized by impaired ␤-cell response to increased insulin requirements during pregnancy (5, 18). As insulin sensitivity and ␤-cell function remain impaired after delivery in several cases (18, 30) an early postgestational risk stratification via the 2-h, 75-g oral glucose tolerance test (OGTT) is indicated to identify subgroups with particularly high risk for the later development of Type 2 diabetes (e.g., subjects with impaired fasting glucose or impaired glucose tolerance) (12, 19, 22) . We have previously noticed, that the clinical information from the postpartum OGTT could be considerably enhanced by including the information of additional glucose measurements (and particularly glucose levels at 60 min after ingestion), as they showed improved association with the underlying pathogenic mechanisms (10). In addition, several mathematical equations derived from OGTT parameters, including frequent measurements of insulin, C-peptide, and glucose, and body composition were proposed to approximate insulin sensitivity and ␤-cell function derived from glucose clamp techniques (4) and were also used to improve our understanding of postpartum implications of this disease (23, 30). Apart from this, the extent to which each of the underlying pathophysiological mechanisms might contribute to variations in OGTT dynamics was not directly studied until now. However, a detailed evaluation of the dominant patterns of OGTT dynamics would be of particular importance to provide full insight into the biological processes beyond hyperglycemia and impaired glucose disposition at early postpartum to allow an accurate risk stratification.
function remain impaired after delivery in several cases (18, 30) an early postgestational risk stratification via the 2-h, 75-g oral glucose tolerance test (OGTT) is indicated to identify subgroups with particularly high risk for the later development of Type 2 diabetes (e.g., subjects with impaired fasting glucose or impaired glucose tolerance) (12, 19, 22) . We have previously noticed, that the clinical information from the postpartum OGTT could be considerably enhanced by including the information of additional glucose measurements (and particularly glucose levels at 60 min after ingestion), as they showed improved association with the underlying pathogenic mechanisms (10) . In addition, several mathematical equations derived from OGTT parameters, including frequent measurements of insulin, C-peptide, and glucose, and body composition were proposed to approximate insulin sensitivity and ␤-cell function derived from glucose clamp techniques (4) and were also used to improve our understanding of postpartum implications of this disease (23, 30) . Apart from this, the extent to which each of the underlying pathophysiological mechanisms might contribute to variations in OGTT dynamics was not directly studied until now. However, a detailed evaluation of the dominant patterns of OGTT dynamics would be of particular importance to provide full insight into the biological processes beyond hyperglycemia and impaired glucose disposition at early postpartum to allow an accurate risk stratification.
This problem might be resolved by the use of principal components analysis (PCA), a statistical procedure aiming to reduce the dimensionality of a large number of correlated measurements (e.g., OGTT data) to a fewer number of uncorrelated variables (i.e., principal components), explaining most of the variation of the original data (14) . PCA or related methods (such as factor analysis) are quite suitable for interrelated metabolic variables and have been previously used in the context of identifying the underlying mechanisms of the "metabolic syndrome" (e.g., 13 ). Moreover, the derived components might be helpful to study the relation of history with GDM with Type 2 diabetes progression during the follow-up period.
Therefore, this report aimed to address the following major objectives: 1) to find the most relevant components, explaining the majority of the variation of glucose, insulin, and C-peptide dynamics by PCA; 2) to explain these principal components by meanings of glucose disposal parameters derived from an independent reference method; and 3) to examine their long-term trajectories and, moreover, their association with the later development of overt diabetes in the context of females with recent history of GDM.
MATERIALS AND METHODS

Study participants and experimental procedures.
A description of the "Vienna Post-Gestational Diabetes Project" was reported elsewhere (e.g., 12, 30) . In short, 110 females 3-6 mo after pregnancy with GDM [pGDM, whereby GDM was diagnosed according to (21) ] and 41 women after gestation without GDM (controls) were included 3 to 6 mo after delivery between June 1999 and December 2003. Several experimental assessments were performed for a detailed metabolic characterization of the study population including an extended 3-h, 75-g OGTT after at least 8 h fasting with measurements of glucose, insulin, and C-peptide, as well as a 3-h frequently sampled intravenous glucose tolerance test (FSIGT) to assess the whole body insulin sensitivity index (SI FSIGT) by minimal model analysis (25, 26) as well as ␤-cell function [⌬AIRG, i.e., the incremental short-term insulin response at 3 to 10 min after intravenous glucose load (16) ]. Insulin sensitivity and ␤-cell function were additionally estimated from OGTT data by using the oral glucose insulin sensitivity index (OGIS) (20) and the insulinogenic index (IGI ϭ ⌬insulin30/ ⌬glucose30) (31), respectively. Insulin sensitivity from fasting conditions was described by the quantitative insulin sensitivity check index (QUICKI) (17) . Females with history of GDM (pGDM) were followed-up until March 2013 to identify n ϭ 25 subjects with diabetes manifestation (median: 6.7 years, interquartile range: 4.2-11.6 yr for subjects included in the present report). Overt diabetes was diagnosed, if fasting or 2 h after glucose load, levels exceeded 126 mg/dl (7.0 mmol/l) or 200 mg/dl (11.1 mmol/l), respectively.
The study was approved by the Ethics Committee of the Medical University of Vienna and was performed in accordance with the Declaration of Helsinki. All participants gave written informed consent.
Laboratory methods. Insulin, C-peptide, glucose, and lipids (triglycerides, LDL, HDL, total cholesterol) were measured according to the international standard laboratory methods at our certified Department of Medical and Chemical Laboratory Diagnostics (http://www. kimcl.at, 14.2.2015) . Parameters of subtle inflammation were assessed by following commercial laboratory kits: ICAM-1 (ELISA; British Biotechnology Product); PAI-1 (ELISA, Technoclone); IL-6 (ELISA; R&D Systems); usCRP (N High Sensitivity CRP Reagent; BN Systems).
Statistical analysis. Principal components analysis, or PCA, is a statistical procedure aiming to reduce the dimensionality of multiple interrelated measures to a set of linearly uncorrelated variables by an orthogonal transformation of the original variables, which explain a large proportion of their variance (14) . For this purpose, we used a penalized singular value decomposition as proposed by Witten et al. (32) , including measures of glucose, insulin, and C-peptide at fasting state, as well as 30, 60, 90, and 120 min after oral glucose load. Age and body mass index (BMI) were additionally included to give more accurate estimates. Hence, PCA was performed on a total of 17 variables, which is a reliable choice, given the sample size of n ϭ 151 females. Data transformations were performed in case of skewed distributed baseline variables as indicated by descriptive analysis (ln[xϩ1] for SI FSIGT, ⌬AIRG, and IGI; sqrt[x] for C-peptide; ln[x] for insulin and BMI). Missing baseline data (i.e., OGTTs were performed, but single measurements of this examination were missing) occurred in n ϭ 7 subjects (median ϭ 1.0, min ϭ 1.0 and max ϭ 6.0 missing parameters per subject). Hence, multiple imputations (including all available OGTT data, BMI, age, and GDM status) were performed to estimate the missing values by the mean of m ϭ 50 complete data sets. Moreover, all variables were centered and standardized (i.e., rescaled to a mean of 0 and a standard deviation of 1) before performing the PCA. The tuning parameter ( ϭ 3.99692) for the penalization was selected by 10-fold cross-validation.
Subsequently, component scores were further analyzed by standard procedures: Differences between two groups (e.g., controls vs. GDM) were assessed by Student's t-test and summarized by means and standard deviations. Their associations with continuous variables were assessed by correlation analysis (Pearson's product moment correlation or Spearman's rank correlation) and multivariable linear regression models, respectively. The proportional hazard model (and a survival regression to account for interval censoring as a sensitivity analysis) was used to examine the associations with the incidence of Type 2 diabetes during the follow-up period. Proportional hazard models were compared in terms of C-index, a measure of concordance comparable to the commonly used area under the receiver operating characteristic curve derived from logistic regression. Longitudinal data were examined by a joint model (shared parameter model) to combine information derived from mixed effects (longitudinal process) and proportional hazard regression (time to event process) to Data are expressed as means Ϯ SD for the total population, as well as divided for history of gestational diabetes mellitus (GDM) and controls. BMI, body mass index. Values are given for glucose (g), insulin (i), and C-peptide (cp) for fasting as well as 30, 60, 90, and 120 min after oral glucose load for pregnant subjects with history of GDM (pGDM; n ϭ 110) vs. controls (n ϭ 41). *Log transformation (ln). **Square-root transformation (sqrt). account for possible nonrandom dropouts. For the longitudinal processes, only random intercepts were used, as the additional inclusion of a random slope or a spatial exponential covariance structure showed no significant improvement of the models in separate analyses. For this approach, 95% confidence intervals (CI) were calculated by 1,000-fold stratified bootstrap replicates.
Statistical analysis was performed with R (v. 3.1.1) particularly using the R-packages "mice" for multiple imputations, "PMA", "survival", "joineR", for data analysis, as well as "lattice" and "scatterplot3d" for visualizations) (28) . The two-sided significance level was set to 0.05. No adjustment for multiplicity was considered for this observational study.
RESULTS
Principal components analysis of baseline data.
A summary of baseline data (OGTT measurements, age, and BMI) is provided in Table 1 , illustrating differences between females with history of GDM and controls in BMI, and OGTT dynamics of glucose, insulin, and C-peptide, as expected. The first two principal components (PC1 and PC2) explained a major amount of the variation of dynamic measures of glucose insulin and C-peptide, including BMI and age (cumulatively 64.4% of the total variance). The third principal component (PC3) additionally explained 7.1%. Much less was explained by the remaining 14 components (Fig. 1A) . A detailed analysis of the loadings (i.e., how strong original variables are related to each principal component) is presented in Fig. 1B (biplot explaining the contributing effect of each variable on PC1 and PC2) and Fig. 2 (visualizing the loadings of the included variables on all components): PC1 showed negative loadings on all included variables (the strongest effect was reported for insulin and C-peptide particularly at 90 and 120 min after oral glucose load) and accounts for 47.1% of the total variation of all included variables (Fig. 1B) . As provided in Table 2 , it is positively related to SI FSIGT and OGIS and, moreover, inversely correlated with parameters of subtle inflammation (i.e., usCRP, PAI-1, and ICAM-1), as well as serum lipids, indicating that this component generally covers insulin sensitivity. However, also moderate negative association with ⌬AIRG was reported. In contrast, PC2 (explained 17.3% of the variance) showed positive loadings on glucose levels during the OGTT, but it was negatively related to insulin and C-peptide levels (Fig. 1B, Fig. 2 ). As it was inversely associated with ⌬AIRG and IGI, it could be interpreted as a component mainly covering ␤-cell failure. A lesser amount of the variance was explained by PC3, with loadings, particularly on BMI, as well as fasting levels of glucose, insulin, and C-peptide concentrations (Fig. 2) . It was found to be significantly related to insulin resistance at fasting state (i.e., nega- tively related with QUICKI) and, therefore, might rather determine hepatic insulin resistance. The associations between FSIGT-derived insulin sensitivity and ␤-cell function with PC1 and PC2 are visualized in Fig. 3 . Moreover, the exact loading matrix of the first three components are provided in Table 3 .
Subjects with history of GDM substantially differed from the controls in the scores of PC1 (Ϫ0.53 Ϯ 2.77 vs. 1.41 Ϯ 2.51, P Ͻ 0.001) and PC2 (0.32 Ϯ 1.78 vs. Ϫ0.86 Ϯ 1.18, P Ͻ 0.001 for pGDM vs. controls). Furthermore, no interactions between principal components and GDM status with respect to FSIGT-derived insulin sensitivity and ␤-cell function were observed.
Assessment of the relation with Type 2 diabetes progression. Proportional hazard models revealed that particularly the first three principal components were significantly associated with the later development of Type 2 diabetes in females with history of GDM [PC1: heart rate (HR), 0.75; 95% confidence interval (CI), 0.65 to 0.87; P Ͻ 0.001 (C-index: 0.75); PC2: HR, 1.90; 95% CI, 1.45 to 2.48; P Ͻ 0.001 (C-index: 0.80); PC3: HR, 1.79; 95% CI, 1.19 to 2.70; P ϭ 0.006 (C-index: 0.65) for univariable analysis, respectively]. The discrimination of the remaining 14 components was clearly inferior (range of C-index: 0.46 to 0.60). These results remained constant in a sensitivity analysis, where diabetes progression was treated as interval censored time to event data. Moreover, a multivariable model, including the scores of all three components revealed superior accuracy in the prediction of Type 2 diabetes (C-index: 0.88) compared with a second model, including log-transformed SI FSIGT and ⌬AIRG (C-index: 0.79). An alternative model, including OGIS and log-transformed IGI, showed a C-index of 0.86. Moreover, a significant interaction between PC1 and PC2 was observed (P ϭ 0.002), indicating that the protective effect of higher scores in PC1 (insulin sensitivity) is attenuated in the presence of higher PC2 (␤-cell failure). However, the inclusion of this interaction showed no major changes in C-statistics (C-index: 0.89).
As visualized in Fig. 4 , the trajectories of principal components scores (change over time) differed significantly between pGDMs who developed overt diabetes compared with those with no reported diabetes progression (joint model): ␤ group:time ϭ Ϫ0.52, 95% CI Ϫ0.86 to Ϫ0.33 (PC1); ␤ group:time ϭ 0.40, 95% CI: 0.27 to 0.71 (PC2); ␤ group:time ϭ 0.09, 95% CI: 0.03 to 0.23 (PC3) for changes per year (diabetes progression vs. no progression), respectively. However, it has to be mentioned, that data of OGTT measurements, age, and BMI as summarized by the three principal components starts to change ϳ3 years before overt diabetes manifestation. Before that time (comparable to patients without diabetes manifestation) these values remain constant, as indicated by descriptive analysis.
DISCUSSION
This report aimed to assess the dominant patterns of OGTT dynamics of glucose, insulin, and C-peptide at early postpartum to provide further insight into the biological processes beyond impaired carbohydrate metabolism early after pregnancy with GDM. As a new approach, we used PCA (a method for variable reduction that identifies dominant patterns of correlated data) and identified three principal components (representing insulin sensitivity in different target tissues, physiologic adaptation to insulin resistance, and ␤-cell failure), accounting for 71.5% of the variance of OGTT data, including age and BMI. Moreover, these three components were shown to be strongly related to FSIGT derived parameters of glucose disposal, as well as to the later development of Type 2 diabetes. The results of our novel approach provide useful insights to explain the variation of OGTT dynamics by several biological mechanisms Data are correlation coefficients (r). n, number of observations; PC, principal component; RRS, systolic blood pressure; RRD, diastolic blood pressure; SI, insulin sensitivity index derived from the FSIGT; OGIS, oral glucose tolerance index derived from the OGTT; QUICKI, quantitative insulin sensitivity check index; ⌬AIRG, acute insulin response to glucose derived from the FSIGT; IGI, insulinogenic index; LDL, low-density lipoprotein; HDL, high-density lipiprotein; usCRP, ultrasensitive C-reactive protein; IL-6, interleukin-6; PAI-1, plasminogen activator inhibitor 1; ICAM-1, soluble intracellular adhesion molecule-1. Bolded values show significant difference. *Spearman's rank correlation as used instead of Pearson's product moment correlation due to nonlinear monotonic associations or outliers.
addressing the specific question of pathophysiological relevance and might be useful for risk classification and risk prediction in the pGDM context.
In the past decades, the OGTT has been established as an important instrument in different settings of diabetes care, including risk stratification (i.e., screening for prediabetic conditions) and diagnosis of overt Type 2 diabetes (3). We and others (11, 27) have previously shown that the results of this examination provide superior performance to detect prediabetic conditions compared with nondynamic tests (e.g., HbA1c): For example, one of our previous reports (including a subgroup of the present study) indicated, that HbA1c assessed early after delivery is only a weak surrogate of insulin sensitivity or secretion and gives almost no additive information to glycemic parameters assessed during the OGTT (11) . However, while the strong relation between dynamic OGTT measurements (including insulin, C-peptide, and plasma glucose) and early metabolic changes in the pathogenesis of Type 2 diabetes have been established for quite a long time (2), less research has focused on explaining the variability of OGTT dynamics by meanings of underlying pathophysiological processes. We aimed to close this gap by using principal components analysis and compared the resulting component scores (representing linear combinations of the original variables) with the highest exploratory impact to OGTT-independent parameters of insulin resistance and ␤-cell dysfunction derived from an FSIGT in the context of GDM.
The first and most important component identified by our analysis (PC1) was inversely related to OGTT measurements, age, and BMI and approximately explained half of the variance of the data. In addition, this component was shown to be strongly associated with whole body insulin sensitivity (SI FSIGT ). According to its stronger relation on postprandial concentrations of glucose, insulin, and C-peptide, we suggest, that it rather reflects insulin sensitivity in the skeletal muscle, the possible primary defect in Type 2 diabetes, which was previously shown to be closely linked to dynamic measurements in the postprandial state (8) . In contrast, PC3 (which explained quite lower amount of the data compared with PC1) had positive loadings on fasting levels in addition to BMI and moderate negative loadings on postprandial levels, indicating that it might be rather related to hepatic insulin resistance. The concept that fasting and postprandial measurements of glucometabolic parameters during the OGTT are affected by impaired insulin sensitivity in different target issues (i.e., liver and skeletal muscle) was indicated by many previous observations. The pathogenic mechanisms beyond this issue could be summarized as follows [for a detailed review see (8) and (1)]: In the postabsorptive state fasting plasma glucose concentrations are mainly determined by gluconeogenesis in the liver, which is tightly controlled by basal insulin levels. Following an oral glucose load, insulin is released from the ␤-cells to suppress glycogenolysis (in the liver) and stimulates hepatic and particularly glucose uptake in the muscle (9) . Each of the described mechanisms could be blunted in the presence of insulin resistance, leading to intermediate stages of glucose intolerance: impaired fasting glucose, if insulin resistance occurs in the liver; or impaired glucose tolerance, if insulin resistance occurs in the skeletal muscle (2, 15) . Of note, previous studies have indicated, that the prevalence of fasting and postprandial hyperglycemia differs between some epidemiologic factors, like age and sex (e.g., middle-aged women rather suffer from impaired postprandial hyperglycemia), emphasizing the need for more detailed analyses of OGTT data in different study populations (6) . However, before hyperglycemia may become overt, progressing insulin resistance is compensated due to an increased insulin release from the pancreas and euglycemia is maintained (24) . This tight physiological interplay between impaired insulin sensitivity and increased insulin secretion is also reflected by our results in females with history of GDM, as PC1 was also significantly related with ␤-cell activity (⌬AIRG), although with opposite sign and to a quite lesser extent compared with FSIGT-derived whole body insulin sensitivity. This means that PC1 embodies not only the pathogenic way from insulin sensitivity to insulin resistance but also the physiological adaptation of impaired insulin sensitivity. However, the inability of the pancreas for this compensation (␤-cell failure) is another crucial step in the progression of disturbed carbohydrate metabolism (7) and is primarily mirrored by PC2 (explaining 17.3% of the variance of all included variables). Therefore, we conclude, that both pathogenic factors, impaired insulin sensitivity (mainly represent by the first and third principal component), and ␤-cell failure (mainly represented by the second principal component), as well as their interaction, are present at early postpartum and independently related with the progression to overt diabetes during the follow-up period in our high-risk female study population. This is in accordance with previous studies, indicating impaired insulin sensitivity and ␤-cell function in pGDM females (18, 29) . However, long-term observations are sparsely available, and, thus, time-related changes are less studied at present. Two longitudinal observations, including a subgroup analysis of the present study, demonstrated that both markedly increasing insulin resistance (30) , as well as falling ␤-cell compensation (33) after delivery, are the key mediators for the progression toward Type 2 diabetes, corroborating longitudinal changes of component scores presented in our report (observed for PC1, PC2, and PC3). Of note, descriptive analysis of our data indicated that changes in these parameters started ϳ3 yr before diabetes becomes overt.
Moreover, it has to be mentioned that the combination of these three components at the baseline visit performed well in the prediction of overt diabetes during the follow-up period and showed improved C-statistics compared with alternative models. A possible reason for this observation is that the component scores consisted of the combined information of OGTT dynamics in addition to BMI and age. Hence, we suggest, that the component scores derived by our analysis (calculated as the product of a matrix containing centered and standardized data of OGTT measurements, age, and BMI, as well as a second matrix containing the loadings of each variable on the principal components) might provide appropriate surrogates for glucose disposal (insulin sensitivity or secretion) and, hence, might represent an useful tool for risk stratification in the pGDM context. In this study, we decided to use the first three PC for risk stratification, as they were reasonably explainable by physiological meanings and in contrast to the remaining 14 components performed well in the prediction of Type 2 diabetes progression. However, according to the low number of subjects who developed diabetes during the follow-up period, we assume that there is need for larger observational studies and, moreover, an additional validation in independent populations.
Perspectives and Significance
We conclude that a high amount (71.5%) of the variance of OGTT data, including age and BMI, is explained by three principal components, representing physiological and pathological mechanisms on the pathway of impaired carbohydrate metabolism: status of insulin sensitivity in different target tissues, physiological adaptation to insulin resistance, and ␤-cell failure. The principal component that best described our data was suggested to be closely linked to muscular insulin sensitivity followed by a second component representing ␤-cell dysfunction. Although there is a clear need for larger observa- Glucose (g), insulin (i), and C-peptide (cp) for fasting, as well as 30, 60, 90, and 120 min after oral glucose load. *Log-transformation (ln). **Square-root transformation (sqrt).
tional studies, our report might also provide a further step in the development of post-GDM-specific OGTT indices for glucose disposal, which could be also useful to clinicians, enabling them to give patients an accurate risk stratification after pregnancy with GDM. 
